The World Malaria Report 2018

2

The World Malaria Report 2018: The World malaria report, published annually, provides a comprehensive update on global and regional malaria data and trends. The latest report, released on 19 November 2018, tracks investments in malaria programmes and research as well as progress across all intervention areas: prevention, diagnosis, treatment and surveillance. It also includes dedicated chapters on malaria elimination and on key threats in the fight against malaria.

The report is based on information received from national malaria control programmes and other partners in endemic countries; most of the data presented is from 2017.

Key facts:

  • In 2017, an estimated 219 million cases of malaria occurred worldwide (95% confidence interval [CI]: 203–262 million), compared with 239 million cases in 2010 (95% CI: 219–285 million) and 217 million cases in 2016 (95% CI: 200–259 million).
  • Although there were an estimated 20 million fewer malaria cases in 2017 than in 2010, data for the period 2015–2017 highlight that no significant progress in reducing global malaria cases was made in this timeframe.
  • The incidence rate of malaria declined globally between 2010 and 2017, from 72 to 59 cases per 1000 population at risk. Although this represents an 18% reduction over the period, the number of cases per 1000 population at risk has stood at 59 for the past 3 years.
  • In 2017, there were an estimated 435 000 deaths from malaria globally, compared with 451  000 estimated deaths in 2016, and 607 000 in 2010.
  • Children aged under 5 years are the most vulnerable group affected by malaria. In 2017, they accounted for 61% (266 000) of all malaria deaths worldwide.
  • Nearly 80% of global malaria deaths in 2017 were concentrated in 17 countries in the WHO African Region and India; 7 of these countries accounted for 53% of all global malaria deaths: Nigeria (19%), Democratic Republic of the Congo (11%), Burkina Faso (6%), United Republic of Tanzania (5%), Sierra Leone (4%), Niger (4%) and India (4%).
  • In 2017, an estimated US$ 3.1 billion was invested in malaria control and elimination efforts globally by governments of malaria endemic countries and international partners – an amount slighter higher than the figure reported for 2016.
  • Globally, 85% of ITNs were distributed through free mass distribution campaigns, 8% in antenatal care facilities and 4% as part of immunization programmes.
  • An estimated 276 million rapid diagnostic tests (RDTs) were sold globally in 2017.
  • An estimated 2.74 billion treatment courses of artemisinin-based combination therapy (ACT) were procured by countries over the period 2010–2017. An estimated 62% of these procurements were reported to have been made for the public sector.

ITNs continue to be an effective tool for malaria prevention, even in areas where mosquitoes have developed resistance to pyrethroids. This was evidenced in a large multicountry evaluation coordinated by WHO between 2011 and 2016 across study locations in 5 countries.

Read also:  Safe Motherhood & Reproductive Health Right Act 2075

DOWNLOAD REPORT DOWNLOAD REPORT  DOWNLOAD REPORT

WORLD HEALTH ORGANIZATION


Countries in WHO South-East Asia to intensify efforts to control dengue, eliminate malaria

1st Malaria World Congress 1-5 July 2018

Sustain high-level commitment to beat malaria across the WHO South-East Asia Region

World Malaria Day 2018: #ReadyToBeatMalaria #WorldMalariaDay

Disease Control: Malaria (Background, Vision, Mission, Goals, Objectives & Target), Nepal

 

Print Friendly, PDF & Email
Share.

About Author

Sagun's Blog is a Public Health Information sharing platform created by Sagun Paudel. The main purpose of this blog is to share public health updates.

Please wait...

Subscribe to our newsletter

Want to be notified when our article is published? Enter your email address and name below to be the first to know.